With durable responses, encouraging survival outcomes, and evidence that some patients may become eligible for ...
A new study published in the journal of BMC Surgery found a combination of high-titer pancreatic enzyme and zinc ...
The therapy is a highly advanced form of radiation therapy that uses charged particles in the form of a proton that that gets ...
India’s first government-run artificial intelligence (AI) clinic, launched recently at the Government Institute of Medical ...
Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference Reaching more metastatic uveal melanoma patients ...
Jazz Pharma to Submit Ziihera Data in First-Line HER2-Positive Gastroesophageal Cancer to Regulators
In the Phase III results, Ziihera plus immunotherapy and chemo improved survival outcomes compared to Herceptin plus chemo.
Although the year brought a steady stream of new treatments, tests, and cutting-edge science, experts worry about how politics will impact innovation long term.
Surgery and chemotherapy together improved survival in GIST patients with liver metastases, increasing median cancer-specific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback